معرفی
Kyle Kampman, MD, is a Professor in the Department of Psychiatry at the University of Pennsylvania's Perelman School of Medicine. He specializes in Addiction Psychiatry, focusing on pharmacotherapies for cocaine, alcohol, and opioid dependence. At the University of Pennsylvania, Kampman has been a faculty member since 1994, promoted to Professor in 2012. He also works at the Addiction Recovery Unit of the Philadelphia VA Medical Center, providing integrated medication and psychotherapy treatments.
Education:
- Northwestern University (1981)
- Tulane University School of Medicine (1985)
Kampman’s research centers on developing medications for substance use disorders, with significant contributions to understanding cocaine withdrawal syndrome. He led the creation of the ASAM National Practice Guideline for opioid use disorder treatment. His clinical trials have explored topiramate, modafinil, and combination therapies for addiction.
Scientific Awards:
- Chair of ASAM Guideline Committee for Opioid Use Disorder Treatment Guidelines (2015, 2019)
Kampman’s publications highlight trends in clinical trials for stimulant and opioid use disorders, emphasizing pharmacotherapy development. His grants include NIH/NIDA funding for novel medications and collaborative care models for OUD.
